Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV-Reference-Cited by-同舟云学术

Long-Term Effectiveness of Rilpivirine-Based Single-Tablet Regimens in a Seven-Year, Two-Center Observational Cohort of People Living with HIV

Published:2022-06-01 Issue:6 Volume:38 Page:472-479
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Taramasso Lucia¹^ORCID,Lo Caputo Sergio²,Magnasco Laura¹^ORCID,Briano Federica³,Poliseno Mariacristina²,Bruno Serena Rita²,Ferrara Sergio²,Pincino Rachele³,Sarteschi Giovanni³,Beltramini Sabrina⁴,Sasso Elisabetta⁴,Mora Sara⁵,Giacomini Mauro⁵,Bassetti Matteo³,Di Biagio Antonio³

Affiliation:

1. Infectious Diseases Clinic, Department of Internal Medicine, IRCCS Policlinico San Martino Hospital, Genoa, Italy.

2. Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

3. Infectious Diseases Clinic, Department of Health Sciences, University of Genoa, San Martino Hospital-IRCCS, Genoa, Italy.

4. Pharmacy Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.

5. Department of Informatics, Bioengineering, Robotics and System Engineering, University of Genoa, Genoa, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2021.0161

Reference34 articles.

1. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

2. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

3. Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA)

4. Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial

5. HIV drug therapy duration; a Swedish real world nationwide cohort study on InfCareHIV 2009-2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pillars of long-term antiretroviral therapy success;Pharmacological Research;2023-10

2. Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA);HIV Medicine;2023-07-13